Condition
Proton Pump Inhibitor Adverse Reaction
Total Trials
5
Recruiting
1
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed4
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05815550CompletedPrimary
Delirium Related to Proton Pump Inhibitors Use
NCT05484128Not ApplicableRecruiting
Lactobacillus Reuteri Strain Combination in Children Treated With PPI
NCT06384443CompletedPrimary
Proton Pump Inhibitors in Cirrhotic Patients
NCT06268834Not ApplicableCompletedPrimary
Is Long-Term Proton Pump Inhibitor Use a Cause of Leaky Gut Syndrome
NCT04426994CompletedPrimary
Hypomagnesemia Associated With Proton-Pump Inhibitor Use
Showing all 5 trials